Antengene
Antengene Corporation Limited, headquartered in China, is a pioneering biopharmaceutical company focused on the development and commercialisation of innovative therapies for cancer treatment. Founded in 2017, Antengene has rapidly established itself in the oncology sector, with a strong emphasis on precision medicine and targeted therapies. The company operates primarily in Asia-Pacific regions, aiming to address unmet medical needs through its robust pipeline of novel drug candidates. Antengene's core products include a range of innovative therapies that leverage cutting-edge technology, setting them apart in a competitive market. With notable achievements in clinical trials and strategic partnerships, Antengene is positioned as a key player in the biopharmaceutical industry, committed to improving patient outcomes and advancing cancer care globally.
DitchCarbon Score
How does Antengene's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Antengene's score of 25 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Antengene's reported carbon emissions
In 2023, Antengene reported total carbon emissions of approximately 1,169,980 kg CO2e, with Scope 1 emissions at about 45,220 kg CO2e and Scope 2 emissions at approximately 1,124,760 kg CO2e. This represents a decrease from 2022, where total emissions were about 1,613,260 kg CO2e, with Scope 1 emissions of approximately 551,320 kg CO2e and Scope 2 emissions of about 1,061,940 kg CO2e. Over the past few years, Antengene has shown a commitment to reducing its carbon footprint, although specific reduction targets or initiatives have not been disclosed. The company has consistently reported emissions for Scope 1 and Scope 2, but there is no available data for Scope 3 emissions. Antengene's emissions intensity metrics indicate that in 2023, the GHG emission intensity per employee was about 6,430 kg CO2e, while in 2022, it was approximately 7,230 kg CO2e. This suggests a potential improvement in operational efficiency relative to employee count. Overall, while Antengene has made strides in emissions reporting and has shown a reduction in total emissions, further details on specific climate commitments or reduction targets are not available.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 27,080 | 00,000 | 000,000 | 00,000 |
| Scope 2 | 251,390 | 000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Antengene is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
